Do not eat or drink for 30 minutes after dosing
If you've tried diet and exercise without sustainable results or you're researching GLP-1 medications, metabolic peptides, or body-composition therapies a single consultation can clarify which path actually fits your physiology, your medical history, and your goals
In the United Kingdom, plasma donation eligibility is determined by NHS Blood and Transplant (NHSBT), which maintains strict guidelines to protect both donors and recipients
semaglutide is initiated at 0.5 mg and titrated up to 2.0 mg
This is a regulatory limitation, not a choice we make
Studies show that GLP-1 agonists preferentially reduce visceral (deep belly) fat before subcutaneous fat (the layer under your skin), which is metabolically favorable because visceral fat is linked to insulin resistance, type 2 diabetes, and cardiovascular disease